These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2420883)

  • 1. Interferon sensitive and insensitive MHC variants of a murine thymoma differentially resistant to methotrexate-containing antibody-directed liposomes and immunotoxin.
    Machy P; Arnold B; Aliño S; Leserman LD
    J Immunol; 1986 Apr; 136(8):3110-5. PubMed ID: 2420883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug transfer into lymphoblasts mediated by liposomes bound to distinct sites on H-2 encoded I-A, I-E, and K molecules.
    Machy P; Pierres M; Barbet J; Leserman LD
    J Immunol; 1982 Nov; 129(5):2098-102. PubMed ID: 6811657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytosis and de novo expression of major histocompatibility complex encoded class I molecules: kinetic and ultrastructural studies.
    Machy P; Truneh A; Gennaro D; Hoffstein S
    Eur J Cell Biol; 1987 Dec; 45(1):126-36. PubMed ID: 3443107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between inducible H-2 expression and the immunogenicity of murine skin neoplasms. I. Evidence that the immunogenicity of ultraviolet radiation-chemically induced tumors is associated with their susceptibility to gamma-interferon-mediated enhancement of H-2Kk expression.
    Burnham DK; Mak CK; Webster RJ; Daynes RA
    Transplantation; 1989 Mar; 47(3):533-42. PubMed ID: 2493701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of H-2K vs H-2D class I major histocompatibility complex antigen expression by murine recombinant interferon-gamma.
    Green WR; Phillips JD
    J Immunol; 1986 Aug; 137(3):814-8. PubMed ID: 3088110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma, interferon-alpha/beta, and tumor necrosis factor differentially affect major histocompatibility complex class I expression in murine leukemia virus-induced tumor cell lines.
    Klyczek KK; Murasko DM; Blank KJ
    J Immunol; 1987 Oct; 139(8):2641-8. PubMed ID: 3116091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
    Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
    J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel regulation of an MHC class I gene response to interferon-gamma.
    Schwarz DA; Buhlmann JE; Kuhne MR; Lam TM; White HD; Green WR
    Cell Immunol; 1993 Aug; 150(1):90-100. PubMed ID: 7688271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of MHC-determined antigens in the lung by interferon-gamma.
    Schneeberger EE; DeFerrari M; Skoskiewicz MJ; Russell PS; Colvin RB
    Lab Invest; 1986 Aug; 55(2):138-44. PubMed ID: 3090367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.
    Wong GH; Clark-Lewis I; McKimm-Breschkin L; Harris AW; Schrader JW
    J Immunol; 1983 Aug; 131(2):788-93. PubMed ID: 6408189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
    Mukhopadhyay S; Peiser L; Gordon S
    J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic changes induced by interferon in resting T cells: major enhancement of Ly-6 antigen expression.
    Dumont FJ; Palfree RG; Coker LZ
    J Immunol; 1986 Jul; 137(1):201-10. PubMed ID: 2423601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responses.
    Boog CJ; Boes J; Melief CJ
    J Immunol; 1988 May; 140(10):3331-7. PubMed ID: 2452183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.
    Ljunggren HG; Ohlén C; Höglund P; Yamasaki T; Klein G; Kärre K
    J Immunol; 1988 Jan; 140(2):671-8. PubMed ID: 3335786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
    Tashiro-Yamaji J; Kubota T; Yoshida R
    Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of T hybridomas prepared from a T cell clone with three specificities. Recognition of self + X and allo-H-2 determinants segregates from recognition of Mlsa determinants.
    Webb SR; Okamoto A; Sprent J
    J Immunol; 1988 Sep; 141(6):1828-34. PubMed ID: 2459192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal progenitors identified by their inability to express class I histocompatibility antigens in response to interferon-gamma.
    Bailey KA; Drago J; Bartlett PF
    J Neurosci Res; 1994 Oct; 39(2):166-77. PubMed ID: 7837286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.